A statistical symptom cluster is not automatically a distinct biological disease. A 2009 analysis of stimulant-treatment data identified three classes among primary amphetamine users. The classes mainly differed in symptom severity, including tolerance and withdrawal, rather than establishing separate mechanisms of illness.
The study is historically situated in DSM-IV diagnostic concepts and discussions preceding DSM-5. Its categories should not be presented as current diagnostic instructions or used to classify an individual from a toxicology result.
Which participants were analyzed?
Wu and colleagues performed a secondary analysis of public-use data from a Clinical Trials Network study conducted at eight community-based outpatient treatment programs. The analysis included 415 adults reporting past-year cocaine or amphetamine use.
There were 287 primary cocaine users, 99 primary amphetamine users and 29 dual users. “Primary” here meant reporting one of these stimulant categories without the other during the preceding 12 months. It did not mean that the participant used no alcohol, cannabis, opioids or other substances.
The source questionnaire combined amphetamines and methamphetamine. The data could not determine what proportion used an amphetamine other than methamphetamine. Consequently, the 99-person group cannot be relabeled as 99 analytically confirmed methamphetamine-only users.
What information defined the classes?
The researchers analyzed seven past-year DSM-IV dependence criteria, including tolerance, withdrawal, impaired control, time spent obtaining or using the substance, giving up activities and continued use despite problems.
Latent class analysis estimated groups with different probabilities of endorsing those symptoms. It did not measure blood concentrations, pharmacokinetics, receptor sensitivity or responses to controlled drug doses.
Self-reported tolerance in a diagnostic interview is therefore different from experimentally demonstrating a smaller response at a fixed concentration. The word refers to related ideas, but the measurements are not interchangeable.
Which amphetamine classes were identified?
A three-class model fit the primary amphetamine group better than the tested four-class alternative. The authors labeled approximately 11% as non-dependence, 31% as intermediate physiological dependence and 58% as physiological dependence.
The intermediate and higher-severity classes had broadly similar symptom profiles but different endorsement probabilities. Their mean numbers of endorsed criteria were 4.3 and 6.7, compared with 0.6 in the non-dependence class.
All members assigned to the highest-severity class and 97% of the intermediate class met the study’s DSM-IV dependence definition. None of the non-dependence class did. These are relationships within this model and selected treatment sample, not prevalence estimates for the general population.
Did the cocaine group have the same structure?
No. A four-class model was selected for the 287 primary cocaine users. It included classes characterized by compulsive use without prominent physiological symptoms, tolerance with compulsive use, a high-symptom physiological-dependence profile, and low or absent dependence symptoms.
In the amphetamine group, reported withdrawal was common—82%, compared with 57% in the cocaine group—and clustered with other symptoms. The authors considered that one reason the model did not separate an additional compulsive-use-only amphetamine class.
This difference does not prove that such a subgroup cannot exist. Class structure depends on sample composition, symptom measurement, sample size and model selection. The smaller amphetamine sample also supported fewer stable distinctions.
What did the sex-related findings show?
Among primary amphetamine users, 71% of women and 44% of men were assigned to the highest-severity class; 20% and 42%, respectively, were assigned to the intermediate class. The reported overall association had p=.022.
These percentages concern classification within a treatment-seeking sample. They do not establish that female sex caused greater dependence severity, that every woman had a more severe disorder, or that biological sex differences explained the association.
The authors discussed possible differences in help-seeking and other factors, but did not directly test a complete causal explanation. Group membership also cannot identify an individual’s clinical needs without assessment.
Why is “national” different from nationally representative?
The programs were geographically diverse, which strengthened the analysis compared with a single-site sample. Recruitment nevertheless occurred among people attending selected treatment programs. It was not a national probability survey of stimulant users.
People outside treatment, people at other types of programs and people with different substance-use patterns may have different symptom distributions. Memory and reporting errors could affect the self-reported criteria. The 29-person dual-use group was too small for a separate latent-class analysis.
The estimated classification error for the selected amphetamine model was .08. That model quantity is not an 8% laboratory drug-test error rate, nor proof that every assigned class was known with certainty.
What remains useful today?
The historical study demonstrates that a broad stimulant label can conceal differences in symptoms, co-use and treatment context. It also illustrates the need to distinguish a statistical grouping from a biological mechanism and a historical research definition from current diagnostic practice.
No concentration cutoff, impairment threshold or individual prognosis follows from these classes. The appropriate use of the evidence is to preserve heterogeneity and ask which symptoms and exposures were actually assessed.
Scientific source
Wu LT, Blazer DG, Patkar AA, Stitzer ML, Wakim PG, Brooner RK. Heterogeneity of Stimulant Dependence: A National Drug Abuse Treatment Clinical Trials Network Study. American Journal on Addictions. 2009;18(3):206–218. doi:10.1080/10550490902787031. Full-text author manuscript. Historical secondary analysis of human treatment-sample data using DSM-IV criteria.
Leave a Reply